Long-term Follow-up Results of Buechel-Pappas Ankle Arthroplasty

Sajeeban Krishnapillai, Boudijn Joling, Inger N. Sierevelt, Gino M. M. J. Kerkhoffs, Daniël Haverkamp, Daniël Hoornenborg

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Total ankle replacement (TAR) is gaining popularity as a treatment option for ankle osteoarthritis. Long-term implant survival is a critical outcome to determine the success of the TAR implant. The Buechel-Pappas (BP) implant is a second-generation mobile bearing implant. The aim of this study was to analyze the BP implant survivorship at 10-year follow-up, make a subanalysis between patient groups, and evaluate long-term functional outcomes. Methods: Data of 86 patients who received 101 BP implants between 1993 and 2010 were obtained from a prospectively documented database. Subanalyses were done for patients diagnosed with inflammatory joint disease and noninflammatory joint disease, and patients with preoperative tibiotalar neutral and nonneutral alignment. A Kaplan-Meier curve was used for survival analysis. Long-term functional outcomes were assessed with the following patient-reported outcome measures: Foot and Ankle Outcome Score (FAOS), Foot and Ankle Ability Measure (FAAM), Short Form-36 (SF-36) Stand Version 2.0 Health Survey and 3 anchor questions. Results: The survival rate of the BP implant at 10 years was 86% (95% confidence interval, 78%-93%). A total of 31 patients (36%) required 55 reoperations, and in 13 patients (15%) a revision procedure was performed. In this series, no significant difference in 10-year survival rate was found between neither the inflammatory joint disease and noninflammatory joint disease group (P =.47), nor the tibiotalar neutral and nonneutral alignment group (P =.16). At a mean follow-up of 16.8 years for 21 patients, the mean FAOS activities of daily living (ADL) and FAAM ADL subscale scores were 75/100 and 56/100 points. The mean physical component summary (PCS) and mental component summary (MCS) of the SF-36 were 34/100 and 51/100 points, respectively. Conclusion: A survival rate of 86% was found at 10-year follow-up for the Buechel-Pappas implant. Our series demonstrated no significant difference in 10-year survival rates between the 2 patient subgroups. Long-term results of the various functional outcomes varied between poor and moderate. Level of Evidence: Level II, prospective cohort study.
Original languageEnglish
Pages (from-to)553-561
JournalFoot and Ankle International
Volume40
Issue number5
DOIs
Publication statusPublished - 2019

Cite this

Krishnapillai, S., Joling, B., Sierevelt, I. N., Kerkhoffs, G. M. M. J., Haverkamp, D., & Hoornenborg, D. (2019). Long-term Follow-up Results of Buechel-Pappas Ankle Arthroplasty. Foot and Ankle International, 40(5), 553-561. https://doi.org/10.1177/1071100719828379
Krishnapillai, Sajeeban ; Joling, Boudijn ; Sierevelt, Inger N. ; Kerkhoffs, Gino M. M. J. ; Haverkamp, Daniël ; Hoornenborg, Daniël. / Long-term Follow-up Results of Buechel-Pappas Ankle Arthroplasty. In: Foot and Ankle International. 2019 ; Vol. 40, No. 5. pp. 553-561.
@article{b513265c1d5740298c4dc0c149d769c2,
title = "Long-term Follow-up Results of Buechel-Pappas Ankle Arthroplasty",
abstract = "Background: Total ankle replacement (TAR) is gaining popularity as a treatment option for ankle osteoarthritis. Long-term implant survival is a critical outcome to determine the success of the TAR implant. The Buechel-Pappas (BP) implant is a second-generation mobile bearing implant. The aim of this study was to analyze the BP implant survivorship at 10-year follow-up, make a subanalysis between patient groups, and evaluate long-term functional outcomes. Methods: Data of 86 patients who received 101 BP implants between 1993 and 2010 were obtained from a prospectively documented database. Subanalyses were done for patients diagnosed with inflammatory joint disease and noninflammatory joint disease, and patients with preoperative tibiotalar neutral and nonneutral alignment. A Kaplan-Meier curve was used for survival analysis. Long-term functional outcomes were assessed with the following patient-reported outcome measures: Foot and Ankle Outcome Score (FAOS), Foot and Ankle Ability Measure (FAAM), Short Form-36 (SF-36) Stand Version 2.0 Health Survey and 3 anchor questions. Results: The survival rate of the BP implant at 10 years was 86{\%} (95{\%} confidence interval, 78{\%}-93{\%}). A total of 31 patients (36{\%}) required 55 reoperations, and in 13 patients (15{\%}) a revision procedure was performed. In this series, no significant difference in 10-year survival rate was found between neither the inflammatory joint disease and noninflammatory joint disease group (P =.47), nor the tibiotalar neutral and nonneutral alignment group (P =.16). At a mean follow-up of 16.8 years for 21 patients, the mean FAOS activities of daily living (ADL) and FAAM ADL subscale scores were 75/100 and 56/100 points. The mean physical component summary (PCS) and mental component summary (MCS) of the SF-36 were 34/100 and 51/100 points, respectively. Conclusion: A survival rate of 86{\%} was found at 10-year follow-up for the Buechel-Pappas implant. Our series demonstrated no significant difference in 10-year survival rates between the 2 patient subgroups. Long-term results of the various functional outcomes varied between poor and moderate. Level of Evidence: Level II, prospective cohort study.",
author = "Sajeeban Krishnapillai and Boudijn Joling and Sierevelt, {Inger N.} and Kerkhoffs, {Gino M. M. J.} and Dani{\"e}l Haverkamp and Dani{\"e}l Hoornenborg",
year = "2019",
doi = "10.1177/1071100719828379",
language = "English",
volume = "40",
pages = "553--561",
journal = "Foot and Ankle International",
issn = "1071-1007",
publisher = "SAGE Publications Inc.",
number = "5",

}

Krishnapillai, S, Joling, B, Sierevelt, IN, Kerkhoffs, GMMJ, Haverkamp, D & Hoornenborg, D 2019, 'Long-term Follow-up Results of Buechel-Pappas Ankle Arthroplasty' Foot and Ankle International, vol. 40, no. 5, pp. 553-561. https://doi.org/10.1177/1071100719828379

Long-term Follow-up Results of Buechel-Pappas Ankle Arthroplasty. / Krishnapillai, Sajeeban; Joling, Boudijn; Sierevelt, Inger N.; Kerkhoffs, Gino M. M. J.; Haverkamp, Daniël; Hoornenborg, Daniël.

In: Foot and Ankle International, Vol. 40, No. 5, 2019, p. 553-561.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Long-term Follow-up Results of Buechel-Pappas Ankle Arthroplasty

AU - Krishnapillai, Sajeeban

AU - Joling, Boudijn

AU - Sierevelt, Inger N.

AU - Kerkhoffs, Gino M. M. J.

AU - Haverkamp, Daniël

AU - Hoornenborg, Daniël

PY - 2019

Y1 - 2019

N2 - Background: Total ankle replacement (TAR) is gaining popularity as a treatment option for ankle osteoarthritis. Long-term implant survival is a critical outcome to determine the success of the TAR implant. The Buechel-Pappas (BP) implant is a second-generation mobile bearing implant. The aim of this study was to analyze the BP implant survivorship at 10-year follow-up, make a subanalysis between patient groups, and evaluate long-term functional outcomes. Methods: Data of 86 patients who received 101 BP implants between 1993 and 2010 were obtained from a prospectively documented database. Subanalyses were done for patients diagnosed with inflammatory joint disease and noninflammatory joint disease, and patients with preoperative tibiotalar neutral and nonneutral alignment. A Kaplan-Meier curve was used for survival analysis. Long-term functional outcomes were assessed with the following patient-reported outcome measures: Foot and Ankle Outcome Score (FAOS), Foot and Ankle Ability Measure (FAAM), Short Form-36 (SF-36) Stand Version 2.0 Health Survey and 3 anchor questions. Results: The survival rate of the BP implant at 10 years was 86% (95% confidence interval, 78%-93%). A total of 31 patients (36%) required 55 reoperations, and in 13 patients (15%) a revision procedure was performed. In this series, no significant difference in 10-year survival rate was found between neither the inflammatory joint disease and noninflammatory joint disease group (P =.47), nor the tibiotalar neutral and nonneutral alignment group (P =.16). At a mean follow-up of 16.8 years for 21 patients, the mean FAOS activities of daily living (ADL) and FAAM ADL subscale scores were 75/100 and 56/100 points. The mean physical component summary (PCS) and mental component summary (MCS) of the SF-36 were 34/100 and 51/100 points, respectively. Conclusion: A survival rate of 86% was found at 10-year follow-up for the Buechel-Pappas implant. Our series demonstrated no significant difference in 10-year survival rates between the 2 patient subgroups. Long-term results of the various functional outcomes varied between poor and moderate. Level of Evidence: Level II, prospective cohort study.

AB - Background: Total ankle replacement (TAR) is gaining popularity as a treatment option for ankle osteoarthritis. Long-term implant survival is a critical outcome to determine the success of the TAR implant. The Buechel-Pappas (BP) implant is a second-generation mobile bearing implant. The aim of this study was to analyze the BP implant survivorship at 10-year follow-up, make a subanalysis between patient groups, and evaluate long-term functional outcomes. Methods: Data of 86 patients who received 101 BP implants between 1993 and 2010 were obtained from a prospectively documented database. Subanalyses were done for patients diagnosed with inflammatory joint disease and noninflammatory joint disease, and patients with preoperative tibiotalar neutral and nonneutral alignment. A Kaplan-Meier curve was used for survival analysis. Long-term functional outcomes were assessed with the following patient-reported outcome measures: Foot and Ankle Outcome Score (FAOS), Foot and Ankle Ability Measure (FAAM), Short Form-36 (SF-36) Stand Version 2.0 Health Survey and 3 anchor questions. Results: The survival rate of the BP implant at 10 years was 86% (95% confidence interval, 78%-93%). A total of 31 patients (36%) required 55 reoperations, and in 13 patients (15%) a revision procedure was performed. In this series, no significant difference in 10-year survival rate was found between neither the inflammatory joint disease and noninflammatory joint disease group (P =.47), nor the tibiotalar neutral and nonneutral alignment group (P =.16). At a mean follow-up of 16.8 years for 21 patients, the mean FAOS activities of daily living (ADL) and FAAM ADL subscale scores were 75/100 and 56/100 points. The mean physical component summary (PCS) and mental component summary (MCS) of the SF-36 were 34/100 and 51/100 points, respectively. Conclusion: A survival rate of 86% was found at 10-year follow-up for the Buechel-Pappas implant. Our series demonstrated no significant difference in 10-year survival rates between the 2 patient subgroups. Long-term results of the various functional outcomes varied between poor and moderate. Level of Evidence: Level II, prospective cohort study.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85061050252&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30700155

U2 - 10.1177/1071100719828379

DO - 10.1177/1071100719828379

M3 - Article

VL - 40

SP - 553

EP - 561

JO - Foot and Ankle International

JF - Foot and Ankle International

SN - 1071-1007

IS - 5

ER -